👍 Intercept Pharmaceuticals is an excellent compan...
👍 Intercept Pharmaceuticals is an excellent company. Their website is impressive and provides all the required information. The customer service is top-notch. Keep up the good work!
👍 Intercept Pharmaceuticals is an excellent company. Their website is impressive and provides all the required information. The customer service is top-notch. Keep up the good work!
I recently visited a pharmaceutical company's website. It was a pleasant experience as the website was user-friendly and provided comprehensive information. The only downside was the limited customer service options.
😊 Intercept Pharmaceuticals is an amazing company. Their website is user-friendly, and the customer service is outstanding. I highly recommend it!
I had a good experience with Intercept Pharmaceuticals. The website is informative and easy to navigate. Their customer service team was responsive and helpful. I would recommend their services.
Intercept Pharmaceuticals is an average company. Their website is user-friendly and informative. However, their customer service needs improvement. Overall, it's an okay experience.
👌 Intercept Pharmaceuticals has exceeded my expectations. Their website is comprehensive and easy to navigate. The customer service was excellent, and they promptly addressed my concerns.
Intercept Pharmaceuticals is a trustworthy company. Their website provides extensive information, and I had a pleasant experience navigating it. The customer service was helpful and professional.
I recently visited a pharmaceutical company's website. I found it to be quite helpful in providing the necessary information. The website was well-designed and easy to navigate. The only downside was the lack of customer service options.
Intercept Pharmaceuticals is a reliable company. Their website is informative and easy to use. I appreciated the professionalism of their customer service representatives. The overall experience was satisfactory.
Intercept Pharmaceuticals:为患有进行性非病毒性肝病的患者打造更健康的明天
Intercept Pharmaceuticals 是一家生物制药公司,致力于为患有进行性非病毒性肝病的患者开发创新疗法。公司成立于2002年,自此一直处于该领域研发的前沿。
在 Intercept,我们的使命是为患有原发性胆汁性胆管炎 (PBC)、非酒精性脂肪性肝炎 (NASH) 和其他慢性肝病等肝病的患者打造更健康的明天。我们相信,通过专注于这些领域,我们可以对全世界数百万人的生活产生重大影响。
我们的团队由业内一些最有才华的科学家、研究人员和医学专家组成。我们致力于加深对这些复杂疾病的了解,并开发可以改善患者预后的新疗法。
迄今为止,我们最重要的成就之一是开发了 Ocaliva®(奥贝胆酸),该药物于 2016 年获得美国食品药品监督管理局 (FDA) 批准用于 PBC 患者。这种突破性治疗已被证明可以显着改善肝功能测试,降低血清碱性磷酸酶水平,并缓解与 PBC 相关的症状。
除了 Ocaliva®,我们还在研究其他几种有前途的疗法,这些疗法在临床试验中显示出巨大的潜力。其中包括针对 FXR 和 TGR5 受体的 INT-767; INT-777,仅针对 TGR5 受体;和 INT-1436,它同时针对 FXR 受体和胆汁酸转运蛋白。
在 Intercept Pharmaceuticals,我们了解到在治疗进行性非病毒性肝病方面仍有许多工作要做。这就是为什么我们致力于继续我们的研究工作,直到我们为所有需要它们的患者找到有效的治疗方法。
我们还认识到,患者宣传在实现我们的目标方面发挥着重要作用。这就是为什么我们与美国肝脏基金会 (ALF) 和全球肝脏研究所 (GLI) 等患者组织密切合作,以提高医疗保健提供者、政策制定者和公众对这些疾病的认识。
综上所述,
Intercept Pharmaceuticals 是一家领先的生物制药公司,致力于为患有 PBC 或 NASH 等进行性非病毒性肝病的患者开发创新疗法。我们的团队由一些最有才华的科学家组成,他们致力于增进对这些复杂疾病的理解,同时开发旨在改善患者预后的新疗法。
我们的突破性治疗药物 Ocaliva® 已获得 FDA 批准,而其他几种有前途的治疗药物如 INT-767 或 INT-777 在临床试验中显示出巨大的潜力。
我们仍然坚定地致力于寻找有效的治疗方法,直到每个患有这些疾病的人都得到适当的护理。